Literature DB >> 19898891

Gender differences in cholesterol nucleation in native bile: estrogen is a potential contributory factor.

Angela C Brown1, Steven P Wrenn, Nandita Suresh, William C Meyers, Mohammad Z Abedin.   

Abstract

The incidence of gallstone disease is two to three times higher in women than in men, and female sex hormones, particularly estrogens, have been implicated as contributory factors. Cholesterol nucleation is the initial step in gallstone pathogenesis and proceeds from cholesterol-rich phospholipid vesicles. The aim of this study was to investigate if there is a difference in cholesterol nucleation rates in male and female bile and whether estrogen influences nucleation rates by interacting with cholesterol-rich regions known as "lipid rafts" that exist within the cholesterol-phospholipid vesicles of the bile. Cholesterol nucleation from native prairie dog bile and the interaction of estrogens with lipid rafts in model bile solutions were investigated using Förster resonance energy transfer (FRET). Female native bile samples showed a greater reduction in energy transfer than did male native bile, indicating that cholesterol nucleation occurred more readily in female bile than in male bile. Model bile experiments demonstrated that the addition of estrogen has a significant effect, either cholesterol nucleation or raft disruption, but only in samples containing cholesterol-rich rafts. These results suggest that estrogen interacts with cholesterol-rich rafts in vesicles within bile to promote cholesterol nucleation and predispose females to gallstone formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898891     DOI: 10.1007/s00232-009-9214-0

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  69 in total

1.  The determination of phosphorus and phosphatase with N-phenyl-p-phenylenediamine.

Authors:  R L DRYER; A R TAMMES; J I ROUTH
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

2.  Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences.

Authors:  D Q Wang; M C Carey
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

3.  Predictive factors for synchronous common bile duct stones in patients with cholelithiasis.

Authors:  A Alponat; C K Kum; A Rajnakova; B C Koh; P M Goh
Journal:  Surg Endosc       Date:  1997-09       Impact factor: 4.584

Review 4.  NIH Consensus conference. Gallstones and laparoscopic cholecystectomy.

Authors: 
Journal:  JAMA       Date:  1993-02-24       Impact factor: 56.272

5.  The epidemiology of gallbladder disease: observations in the Framingham Study.

Authors:  G D Friedman; W B Kannel; T R Dawber
Journal:  J Chronic Dis       Date:  1966-03

6.  Does bilirubin play a role in the pathogenesis of both cholesterol and pigment gallstone formation? Direct and indirect influences of bilirubin on bile lithogenicity.

Authors:  K Nakai; S Tazuma; H Ochi; K Chayama
Journal:  Biochim Biophys Acta       Date:  2001-12-30

7.  Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms.

Authors:  K P Whiting; C J Restall; P F Brain
Journal:  Life Sci       Date:  2000-07-07       Impact factor: 5.037

8.  Sequential changes in biliary lipids and gallbladder ion transport during gallstone formation.

Authors:  D I Giurgiu; K D Saunders-Kirkwood; J J Roslyn; M Z Abedin
Journal:  Ann Surg       Date:  1997-04       Impact factor: 12.969

9.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile.

Authors:  B F Smith
Journal:  J Lipid Res       Date:  1987-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.